The Procurement of Active Pharmaceutical Ingredient Physostigmine Free Base

Concepts

• salisbury
• other nervous system medicinal products
• dstl
• free base
• procurement of active pharmaceutical ingredient physostigmine
• quantity of physostigmine
• quantity of the active pharmaceutical ingredient
• procurement of active pharmaceutical ingredient physostigmine free base
• purpose of this prior information notice
• share information

Location

Salisbury

Description

The purpose of this Prior Information Notice (PIN) is to: • Share information on Dstl’s current thinking regarding a requirement to supply a quantity of Physostigmine Free Base over the next 5-7 years, with the potential for a long term supply; • Obtain views & feedback on this from the market, including responses to the questions detailed in this document; • Provide the ability for the market to highlight areas of opportunity/innovation that Dstl are not currently aware of; • Use the feedback & information to inform & support the development of the future Business Case(s) & Procurement Strategy. This PIN questionnaire is not a request for a full proposal or bid nor should it be taken to be a call for competition, it is purely to obtain information from early engagement with the market. In supporting a potential wider MOD requirement, Dstl is currently exploring the availability & capacity within the market to supply a quantity of the Active Pharmaceutical Ingredient (API), Physostigmine Free Base (also known as eserine; chemical name 1,2,3,3aβ,8,8aβ-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b] indol-5-yl-methylcarbamate; chemical formula C15H21N3O2; molecular weight 275,36 g/mol). Under consideration is the development, process validation, manufacture & supply of this API with an outline indicative quantity of approx.15kg to 20kg per annum. The PIN questionnaire is seeking to identify where possible that the ultimate requirement is market facing/realistic/deliverable & the potential cost of the approach. Any information shared in response to the questionnaire, will be provided on the basis that it gives Dstl/UK MOD with free & unrestricted use of it in consideration of our requirement. It will not be shared outside of Dstl/UK MOD. Dstl is also interested in responses that propose different approaches or areas of efficiency that subject matter experts consider could be deemed in scope. Dstl gives no guarantee whatsoever that such proposals will be taken forward.

Total Quantity or Scope

Prior Information Notice (PIN) Questionnaire – Procurement of Active Pharmaceutical Ingredient – Physostigmine Free Base Purpose: The purpose of this Prior Information Notice (PIN) questionnaire is to: … • Obtain views and feedback on this from the market, including responses to the questions detailed in this document; … • Use the feedback and information to inform and support the development of the future Business Case(s) and Procurement Strategy. … Background: In supporting a potential wider MOD requirement, Dstl is currently exploring the availability and capacity within the market to supply a quantity of the Active Pharmaceutical Ingredient (API), Physostigmine Free Base (also known as eserine; chemical name 1,2,3,3aβ,8,8aβ-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b] indol-5-yl-methylcarbamate; chemical formula C15H21N3O2; molecular weight 275,36 g/mol). Under consideration is the development, process validation, manufacture and supply of this API with an outline indicative quantity of approx. 15kg to 20kg per annum The Purpose of this PIN questionnaire is to assist in preparing a Business Case and Procurement Strategy for this future requirement. The PIN questionnaire is seeking feedback and advice from the market to help understand and to identify where possible that the ultimate requirement is market facing/realistic/deliverable and the potential cost of the approach; Please note that this is not a request for proposals or tenders at this stage. Any information shared with us in responses to the questionnaire, will be provided on the basis that it gives Dstl/UK MOD with the right to free and unrestricted use of it in consideration of our requirement. It will not, however, be shared outside of Dstl/UK MOD. Miscellaneous: Dstl is also interested in receiving responses that propose different approaches or areas of efficiency that subject matter experts in this field consider could be deemed to be in scope. Dstl gives no guarantee whatsoever that such proposals will be taken forward.

CPV Codes

• 33661700 - Other nervous system medicinal products

Indicators

Other Information

https://contracts.mod.uk/go/940803330180BD2BBCCE Closing date for responses to this PIN is 30 June 2022 23:59 GMT